https://adisinsight.springer.com/trials/700381535?error=cookies_not_supported&code=fb4df03f-b58e-4147-9e3b-8053091b4b39
Efficacy and Safety of Efsubaglutide Alfa Injection 3 Mg Every Two Weeks in Patients with Type 2...
This is a phase III multicenter, randomized, open-label, active-controlled clinical trial with a two-period crossover design, aimed at evaluating the efficacy